chr22-21939572-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_014634.4(PPM1F):c.315G>A(p.Glu105=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0016 in 1,577,870 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0077 ( 23 hom., cov: 33)
Exomes 𝑓: 0.00095 ( 12 hom. )
Consequence
PPM1F
NM_014634.4 synonymous
NM_014634.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.34
Genes affected
PPM1F (HGNC:19388): (protein phosphatase, Mg2+/Mn2+ dependent 1F) The protein encoded by this gene is a member of the PP2C family of Ser/Thr protein phosphatases. PP2C family members are known to be negative regulators of cell stress response pathways. This phosphatase can interact with Rho guanine nucleotide exchange factors (PIX), and thus block the effects of p21-activated kinase 1 (PAK), a protein kinase mediating biological effects downstream of Rho GTPases. Calcium/calmodulin-dependent protein kinase II gamma (CAMK2G/CAMK-II) is found to be one of the substrates of this phosphatase. The overexpression of this phosphatase or CAMK2G has been shown to mediate caspase-dependent apoptosis. An alternatively spliced transcript variant has been identified, but its full-length nature has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 22-21939572-C-T is Benign according to our data. Variant chr22-21939572-C-T is described in ClinVar as [Benign]. Clinvar id is 2047622.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.34 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00766 (1167/152336) while in subpopulation AFR AF= 0.0268 (1112/41566). AF 95% confidence interval is 0.0254. There are 23 homozygotes in gnomad4. There are 547 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 23 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPM1F | NM_014634.4 | c.315G>A | p.Glu105= | synonymous_variant | 3/8 | ENST00000263212.10 | NP_055449.1 | |
PPM1F-AS1 | NR_147620.1 | n.1336C>T | non_coding_transcript_exon_variant | 1/2 | ||||
PPM1F | NM_001410836.1 | c.-190G>A | 5_prime_UTR_variant | 2/7 | NP_001397765.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPM1F | ENST00000263212.10 | c.315G>A | p.Glu105= | synonymous_variant | 3/8 | 1 | NM_014634.4 | ENSP00000263212 | P1 | |
PPM1F-AS1 | ENST00000458178.2 | n.1280C>T | non_coding_transcript_exon_variant | 1/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00763 AC: 1161AN: 152218Hom.: 23 Cov.: 33
GnomAD3 genomes
AF:
AC:
1161
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00199 AC: 381AN: 191762Hom.: 3 AF XY: 0.00139 AC XY: 142AN XY: 102186
GnomAD3 exomes
AF:
AC:
381
AN:
191762
Hom.:
AF XY:
AC XY:
142
AN XY:
102186
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000955 AC: 1361AN: 1425534Hom.: 12 Cov.: 31 AF XY: 0.000833 AC XY: 588AN XY: 705570
GnomAD4 exome
AF:
AC:
1361
AN:
1425534
Hom.:
Cov.:
31
AF XY:
AC XY:
588
AN XY:
705570
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00766 AC: 1167AN: 152336Hom.: 23 Cov.: 33 AF XY: 0.00734 AC XY: 547AN XY: 74486
GnomAD4 genome
AF:
AC:
1167
AN:
152336
Hom.:
Cov.:
33
AF XY:
AC XY:
547
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at